Resonacle Pharma Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.
2016 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Resonacle Pharma Private Limited

Resonacle Pharma Private Limited, a active private limited company, was established on 26 February 2016 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900MH2016PTC273571. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jai Shree Panwar (Manager), Greejesh Kumar Singh (Director). Past directors included Amit Shyammohan Saxena, Jai Shree Panwar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No 503, B Wing, 5Th Floor,Shelton Sapphire, Plot No 18 & 19, Sector-15, Cbd Belapur, Navi Mumbai, Maharashtra, 410614.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900MH2016PTC273571

  • Registration Number

    273571

  • Incorporation Date

    26 February 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -2837.68%
  • Ebitda **** -2103.84%
  • Net Worth -61.70%
  • Total Assets -69.12%
Company report

Resonacle Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Resonacle Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Resonacle Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jai Shree Panwar Manager 26 Feb 2016 Current
Greejesh Kumar Singh Director 26 Feb 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 05 Oct 2021 Past
Pramod Abcsdd Manager - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Resonacle Pharma.

Resonacle Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2837.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.7%.

Resonacle Pharma revenue growth over time
Resonacle Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -69.12%
*******
*******
*******
*******
Profit or Loss
*******
 -2837.68%
*******
*******
*******
*******
Net Worth
*******
 -61.70%
*******
*******
*******
*******
EBITDA
*******
 -2103.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Resonacle Pharma?

In 2020, Resonacle Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Resonacle Pharma?

Unlock and access historical data on people associated with Resonacle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Resonacle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resonacle Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Resonacle Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Resonacle Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Resonacle Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Jai Shree Panwar was appointed as a Manager was appointed as a Manager on 26 Feb 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

  • Director Appointment

    Greejesh Kumar Singh was appointed as a Director was appointed as a Director on 26 Feb 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Resonacle Pharma Private Limited was registered on 26 Feb 2016 with Roc Mumbai & aged 9 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Resonacle Pharma Private Limited?

The CIN of Resonacle Pharma Private Limited is U74900MH2016PTC273571.

Where is Resonacle Pharma Private Limited headquartered?

Resonacle Pharma Private Limited is headquartered at Office No 503, B Wing, 5Th Floor,Shelton Sapphire, Plot No 18 & 19, Sector-15, Cbd Belapur, Navi Mumbai, Maharashtra, 410614.

When was Resonacle Pharma Private Limited incorporated?

Resonacle Pharma Private Limited was incorporated on 26 February 2016.

Who are the current directors of Resonacle Pharma Private Limited?

The current directors of Resonacle Pharma Private Limited are

What is the primary industry of Resonacle Pharma Private Limited?

The primary industry of Resonacle Pharma Private Limited is Trade.

Is Resonacle Pharma Private Limited a listed company?

Resonacle Pharma Private Limited is unlisted.

What is the capital structure of Resonacle Pharma Private Limited?

The authorized capital of Resonacle Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Resonacle Pharma Private Limited?

The compliance status of Resonacle Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available